Released Mar 12, 2026, after the close
10-K filed Mar 12, 2026, 71 days after period end · 0001636422-26-000035
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$74.68M$74.68M derived−6.2% vs Q4 2024−2.2% vs Q3 2025
Net Income-$91.03M-$91.03M derivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$86,080,000N/M
Operating Cash Flowderived$9,912,000N/M
Free Cash Flowderived$9,639,000N/M
Margins · derived
Operating margin-115.3%−93.3 pt vs Q4 2024
Net margin-121.9%−95.9 pt vs Q4 2024
What the release said
The release
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $74.68M | $79.61M | $75.08M | $69.16M |
| Net Income | -$91.03M | -$20.67M | -$30.31M | -$35.78M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR